Radionuclide-labeled gold nanoparticles for nuclei-targeting internal radio-immunity therapy
文献类型：期刊论文
| 作者 | Su, WW; Chen, C; Wang, T; Li, X; Liu, YY; Wang, H; Zhao, S; Zuo, CJ; Sun, GF; Bu, WB |
| 刊名 | MATERIALS HORIZONS
 |
| 出版日期 | 2020-04-01 |
| 期号 | 4页码:1115 |
| ISSN号 | 2051-6347 |
| DOI | 10.1039/c9mh01725a |
| 文献子类 | Article |
| 英文摘要 | Radionuclide therapy is an important form of tumor internal radiation therapy (IRT), but its curative effect is restricted by the low radiation intensity and poor targeting ability of nuclides, which hampers efficient killing of DNA. Moreover, the limited penetration depth and nonuniform dose distribution of rays result in "blind" regions with residual living cancer cells, which increases the risk of tumor metastasis. Herein, we developed a new strategy to tactfully incorporate IRT with immunotherapy to achieve highly efficient synergistic therapy. Specifically, gold nanoparticles (AuNPs) co-modified with radioactive iodine-131 and the twin arginine translocation (TAT) peptide (I-131-AuNPs-TAT) were constructed, in which TAT-guided nuclei targeting provided highly concentrated beta-rays to the most radiosensitive DNA. Meanwhile, beta(-) electrons dashed on AuNPs with a sudden drop in speed can transform into low-dosage X-ray bremsstrahlung radiation. X-rays have a longer penetration depth than beta-rays and are able to induce a strong immune response, thus eliminating the area that is blind to short-range beta-rays resulting from the limited dose distribution. This method, named "internal radio-immunity therapy (IRIT)", is a unique approach that combines IRT with immunotherapy to not only enhance radiotherapeutic efficacy but also broaden the clinical applications of I-131, thereby demonstrating great potential for scientific research and clinical applications. |
| WOS关键词 | DOUBLE-STRAND BREAKS ; MACROPHAGE DIFFERENTIATION ; MOLECULAR MARKER ; T-CELL ; GAMMA-H2AX ; IRRADIATION ; INHIBITION ; ANTITUMOR ; DELIVERY ; DAMAGE |
| WOS研究方向 | Chemistry ; Materials Science |
| 语种 | 英语 |
| 出版者 | ROYAL SOC CHEMISTRY |
| 源URL | [http://ir.sic.ac.cn/handle/331005/28173]  |
| 专题 | 中国科学院上海硅酸盐研究所 |
| 推荐引用方式 GB/T 7714 | Su, WW,Chen, C,Wang, T,et al. Radionuclide-labeled gold nanoparticles for nuclei-targeting internal radio-immunity therapy[J]. MATERIALS HORIZONS,2020(4):1115. |
| APA | Su, WW.,Chen, C.,Wang, T.,Li, X.,Liu, YY.,...&Bu, WB.(2020).Radionuclide-labeled gold nanoparticles for nuclei-targeting internal radio-immunity therapy.MATERIALS HORIZONS(4),1115. |
| MLA | Su, WW,et al."Radionuclide-labeled gold nanoparticles for nuclei-targeting internal radio-immunity therapy".MATERIALS HORIZONS .4(2020):1115. |
入库方式： OAI收割
来源：上海硅酸盐研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。